Hot Features
Premium
Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 556,045 |
|
|||||
| News | - | ||||||
| Day High | 21.23 | Low High |
|||||
| Day Low | 20.74 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Akero Therapeutics Inc | AKRO | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.21 | 1.01% | 21.00 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 20.94 | 20.74 | 21.23 | 21.00 | 20.79 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,132 | 556,045 | US$ 21.06 | US$ 11,710,288 | - | 11.25 - 58.38 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:06:30 | 11 | US$ 21.00 | USD |
Akero Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.18B | 56.30M | - | 0 | -151.76M | -2.70 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Akero Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AKRO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 21.58 | 22.175 | 19.89 | 21.13 | 804,983 | -0.58 | -2.69% |
| 1 Month | 24.54 | 25.43 | 19.89 | 22.68 | 749,650 | -3.54 | -14.43% |
| 3 Months | 23.43 | 37.00 | 15.32 | 25.48 | 1,449,924 | -2.43 | -10.37% |
| 6 Months | 12.33 | 37.00 | 11.25 | 22.11 | 1,276,420 | 8.67 | 70.32% |
| 1 Year | 46.05 | 58.38 | 11.25 | 28.22 | 1,209,047 | -25.05 | -54.40% |
| 3 Years | 28.63 | 58.38 | 7.52 | 29.18 | 738,751 | -7.63 | -26.65% |
| 5 Years | 16.16 | 58.38 | 7.52 | 28.89 | 535,334 | 4.84 | 29.95% |
Akero Therapeutics Description
| Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis. |
